Dispersible dolutegravir to improve HIV treatment for children
A new way to take HIV treatment could soon be on the cards for children living with HIV as ViiV Healthcare submits a new dispersible form of dolutegravir to the US Food and Drug Administration and the European Medicines Agency.
The new formulation, a tablet which is dispersible in water & is strawberry flavoured, has seen positive feedback from the community.
Whilst the dose of DTG for adults is 50mg once daily, children require smaller doses tailored to their age and weight. So the new treatment was formulated in 5mg doses, allowing doctors and parents the ability to tailor the dose.